Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Paganuzzi

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1985
Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinomaS Zanardi, R De Menech, G Pino, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patientsF Boccardo, A Rubagotti, D Amoroso, et al.
Cancer|December 18, 2001
Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinomaA Ardizzoni, M A Cafferata, M Paganuzzi, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1985
Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinomaS Zanardi, R De Menech, G Pino, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patientsF Boccardo, A Rubagotti, D Amoroso, et al.
Cancer|December 18, 2001
Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinomaA Ardizzoni, M A Cafferata, M Paganuzzi, et al.
Pageof 3